On March 24, 2022, KIELTYKA GLADKOWSKI KG LEGAL, as a member of The Polish Life Science Cluster, will take part in networking event with Hermes, the Polish branch of BABU – a non-profit biotechnology companybuilding a bridge between two worlds: the world of private funds and the world of academia.
During the meeting, we will talk about current projects implemented by the company, ideas for new activities – including ideas for cooperation platforms related to biotechnology and medical topics. There will also be information on how to submit your project to the company and what you can gain by acting together. The guest will be Steven Liebich – CEO and Founder of Babu, Worldwide Independent Biotechnology Institute.
KIELTYKA GLADKOWSKI KG LEGAL will take part in the cybersecurity webinar organized on 14 April 2022 by the Wall Street Journal.
The areas explored will be the effect on the existing and new privacy regulations on companies doing business internationally (data transfers between the US and Europe); the effect of global changes to privacy regulations on U.S. companies and consumers; new technologies that regulators and privacy officers need to be aware of.
The webinar will be moderated by David Uberti– Cybersecurity Reporter and David Breg– Deputy Research Director.
KIELTYKA GLADKOWSKI KG LEGAL takes part in the webinar organized by the American Bankruptcy Institute on the impact of the conflict in Ukraine on capital, markets and boardrooms. ABI and a panel of experts, including former U.S. House Speaker John Boehner, Former Ambassador Matthew Kirk and Former Career Ambassador Frank Wisner, will discuss the conflict in Europe, which has generated a maze of rapid legal, political and economic responses from authorities around the globe. Those actions are rippling through capital, markets and boardrooms as businesses grapple with how to respond.
On 30 March 2022 KIELTYKA GLADKOWSKI KG LEGAL will participate in the meeting organized by the Polish Life Science Cluster with the Jagiellonian Center for Drug Development (JCET). It is a unit of the Jagiellonian University in Krakow that conducts research on the mechanism of action of drugs and their therapeutic and toxic effects.
At the Jagiellonian Center for Drug Development there are carried out studies of the preclinical phase, i.e. laboratory work without the participation of patients. Particular emphasis is placed on understanding where side effects of drugs come from and how to predict them before a drug candidate reaches the first volunteers in clinical trials.
Cryptocurrencies have become more and more the reality of our daily lives, and also in arbitration. The event will focus on the basic concepts of cryptocurrencies, their use, current features and challenges in arbitration, commercial disputes over transfers of cryptocurrency and the operation of smart contracts.
